Brief: Purapharm Corp Says FY Profit May Fall More Than 90%
24/01/2018 13:26
Jan 24 (Reuters) - Purapharm Corp Ltd 1498.HK :
* EXPECTED THAT GROUP'S PROFIT FOR YEAR WILL DECLINE
SIGNIFICANTLY BY MORE THAN 90 PCT AND MAY EVEN RECORD A LOSS
* EXPECTED RESULT DUE TO DECLINE IN SALES OF GROUP'S CHINA
CONCENTRATED CHINESE MEDICINE GRANULES ``CCMG'' SEGMENT
Source text for Eikon: ID:nHKS2RZXJR
Further company coverage: 1498.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln